B7‐H3 expression in gastric cancer: A novel molecular blood marker for detecting circulating tumor cells
Abstract
The clinical significance of B7‐H3 expression in gastric cancer remains unclear, although the B7 ligand family plays a critical role in the T cell‐mediated immune response. We therefore investigated B7‐H3 expression as a blood marker of circulating tumor cells and determined correlations with tumor progression in patients with gastric cancer. B7‐H3 expression in gastric cell lines was initially evaluated by immunocytochemistry. Furthermore, we used quantitative RT‐PCR to assess B7‐H3 mRNA expression in four cell lines and in 95 blood specimens from patients with gastric cancer, as well as in 21 samples of peripheral blood lymphocytes from healthy volunteers. B7‐H3 expression in cell lines was identified by immunocytochemistry and quantitative RT‐PCR. Blood specimens from patients with gastric cancer contained significantly more copies of B7‐H3 mRNA than those from healthy volunteers without cancer (P < 0.0001). Levels of B7‐H3 expression significantly correlated with overall stage (P = 0.013). The 5‐year survival rate was significantly lower in patients with high B7‐H3 expression than with low expression (P = 0.02). Multivariate analysis demonstrated that B7‐H3 expression was an independent prognostic factor (P = 0.046). Our results indicate that B7‐H3 appears to be a useful blood marker for predicting tumor progression in gastric cancer. (Cancer Sci 2011; 102: 1019–1024)
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Previous literature has demonstrated that gastric tumors may recur a few years after resection even if a curative R0 according to postoperative pathological diagnosis.
“Previous literature has demonstrated that gastric tumors may recur a few years after resection even if a curative R0 according to postoperative pathological diagnosis 26, 27.”
From Prognostic significance of postoperative pneumonia after curative resection for patients with gastric cancer (2017) · cites this paper as [27]
Cites
TNM Classification of Malignant Tumors
Carter, D. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199810000-00016 · Cited by 6,354 · see citing works
Koizumi, W., Narahara, H., Hara, T., Takagane, A., Akiya, T., Takagi, M., Miyashita, K., Nishizaki, T., Kobayashi, O., Takiyama, W., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70035-4 · Cited by 1,849 · see citing works
B7-H3: A costimulatory molecule for T cell activation and IFN-γ production
Chapoval, A. I., Ni, J., Lau, J. S., Wilcox, R. A., Flies, D. B., Liu, D., Dong, H., Sica, G., Zhu, G., Tamada, K., et al. (2001) · Nature Immunology · doi:10.1038/85339 · Cited by 1,013 · see citing works
Hodi, F. S., Mihm, M. C., Soiffer, R. J., Haluska, F. G., Butler, M., Seiden, M. V., Davis, T., Henry-Spires, R., MacRae, S., Willman, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0830997100 · Cited by 1,006 · see citing works
Beck, K. E., Blansfield, J. A., Tran, K. Q., Feldman, A. L., Hughes, M. S., Royal, R. E., Kammula, U. S., Topalian, S. L., Sherry, R. M., Kleiner, D., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.5716 · Cited by 833 · see citing works
Dicken, B. J., Bigam, D. L., Cass, C. E., et al. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000149300.28588.23 · Cited by 693 · see citing works
Sanderson, K. M., Scotland, R., Lee, P. P., Liu, D., Groshen, S. G., Snively, J., Sian, S., Nichol, G. M., Davis, T. A., Keler, T., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.128 · Cited by 432 · see citing works
Bostick, P. J., Chatterjee, S., Chi, D. D., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2632 · Cited by 355 · see citing works
The B7 Family and Cancer Therapy: Costimulation and Coinhibition
Zang, X., & Allison, J. P. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1030 · Cited by 335 · see citing works
B7-H3 and B7-H4 expression in non-small-cell lung cancer
Sun, Y., Wang, Y., Zhao, J., Gu, M., Giscombe, R., Lefvert, A. K., & Wang, X. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2006.05.012 · Cited by 313 · see citing works
Castriconi, R., Dondero, A., Augugliaro, R., Cantoni, C., Carnemolla, B., Sementa, A. R., Negri, F., Conte, R., Corrias, M. V., Moretta, L., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405025101 · Cited by 293 · see citing works
Crispen, P. L., Sheinin, Y. M., Roth, T. J., Lohse, C. M., Kuntz, S. M., Frigola, X., Thompson, R. H., Boorjian, S. A., Dong, H., Leibovich, B. C., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0536 · Cited by 272 · see citing works
Roth, T. J., Sheinin, Y., Lohse, C. M., Kuntz, S. M., Frigola, X., Inman, B. A., Krambeck, A. E., Mckenney, M. E., Karnes, R. J., Blute, M. L., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1068 · Cited by 267 · see citing works
Pharmacokinetic study of S-1, a novel oral fluorouracil antitumor drug.
Hirata, K., Horikoshi, N., Aiba, K., et al. (1999) · PubMed · Cited by 227 · see citing works
Phase I Pharmacokinetic Study of S-1 Plus Cisplatin in Patients With Advanced Gastric Carcinoma
Ajani, J. A., Faust, J., Ikeda, K., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.917 · Cited by 182 · see citing works
Disparities in Gastric Cancer Chemotherapy Between the East and West
Ohtsu, A., Yoshida, S., & Saijo, N. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.9758 · Cited by 164 · see citing works
Jung, R., Petersen, K. U., Krüger, W., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690778 · Cited by 156 · see citing works
A Pilot Study of CTLA-4 Blockade after Cancer Vaccine Failure in Patients with Advanced Malignancy
O’Mahony, D., Morris, J. C., Quinn, C., Gao, W., Wilson, W. H., Gause, B. L., Pittaluga, S., Neelapu, S. S., Brown, M. R., Fleisher, T. A., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1974 · Cited by 154 · see citing works
Wu, C., Jiang, J., Tan, M., Zhu, Y., Ji, M., Xu, K., Zhao, J., Zhang, G., & Zhang, X. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i3.457 · Cited by 141 · see citing works
Chen, Y.-W., Tekle, C., & Fodstad, Ø. (2008) · Current Cancer Drug Targets · doi:10.2174/156800908785133141 · Cited by 114 · see citing works
Prognostic Value of Carcinoembryonic Antigen, CA 19-9 and CA 72-4 in Gastric Carcinoma
Gaspar, M. J., Arribas, I., Coca, M., et al. (2001) · Tumor Biology · doi:10.1159/000050633 · Cited by 111 · see citing works
Arigami, T., Natsugoe, S., Uenosono, Y., et al. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000201453.65534.f1 · Cited by 108 · see citing works
Self-citationDavis, P. A., & Sano, T. (2001) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00131-1 · Cited by 107 · see citing works
Miyazono, F., Natsugoe, S., Takao, S., et al. (2001) · Annals of Surgery · doi:10.1097/00000658-200102000-00007 · Cited by 100 · see citing works
Self-citation有上, 貴. (2006) · Medical Entomology and Zoology · Cited by 97 · see citing works
Arigami, T., Natsugoe, S., Uenosono, Y., Arima, H., Mataki, Y., Ehi, K., Yanagida, S., Ishigami, S., Hokita, S., & Aikou, T. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602739 · Cited by 93 · see citing works
Self-citationThe prognostic value of serum and immunohistochemical tumour markers in advanced gastric cancer
Webb, A., Scott-Mackie, P., Cunningham, D., et al. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(95)00504-8 · Cited by 72 · see citing works
Miyazono, F., Takao, S., Natsugoe, S., et al. (1999) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)00086-0 · Cited by 65 · see citing works
Self-citationCurrent status and future prospects of chemotherapy for metastatic gastric cancer: a review
Ohtsu, A. (2005) · Gastric Cancer · doi:10.1007/s10120-005-0324-9 · Cited by 64 · see citing works
Nakashima, S., Natsugoe, S., Matsumoto, M., et al. (2003) · Surgery · doi:10.1067/msy.2003.9 · Cited by 62 · see citing works
Self-citationUchikura, K., Takao, S., Nakajo, A., et al. (2002) · Annals of Surgical Oncology · doi:10.1007/bf02573871 · Cited by 57 · see citing works
Validation of staging systems for gastric cancer
Yamashita, K., Sakuramoto, S., 菊池, 史., et al. (2008) · Gastric Cancer · doi:10.1007/s10120-008-0466-7 · Cited by 49 · see citing works
Current approaches to gastric cancer in Korea.
Park, J., & Kim, Y. H. (2008) · PubMed · Cited by 49 · see citing works
Mataki, Y., Takao, S., Maemura, K., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0130 · Cited by 41 · see citing works
Koga, T., Tokunaga, E., Sumiyoshi, Y., et al. (2008) · PubMed · Cited by 40 · see citing works
A comparison of gastric cancer between Japan and China
Li, Z., & Kaminishi, M. (2009) · Gastric Cancer · doi:10.1007/s10120-008-0495-2 · Cited by 26 · see citing works
Katanoda, K., & Yako-Suketomo, H. (2008) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyn150 · Cited by 18 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Tu, R., Lin, J., Li, P., Xie, J., Wang, J., Lu, J., Chen, Q., Cao, L., Lin, M., Zheng, C., et al. (2017) · Cancer Medicine · doi:10.1002/cam4.1163 · Cited by 48 · see citing works
- Authors
- Arigami, T., Uenosono, Y., Hirata, M., Yanagita, S., Ishigami, S., & Natsugoe, S.
- Affiliations
- Kagoshima University (JP)
- Venue
- Cancer Science
- Publisher
- Wiley
- Published
- 2011-02-17
- Volume
- 102
- Issue
- 5
- Pages
- 1019-1024
- ISSN
- 1347-9032 (ISSN-L)
- 1349-7006
- OpenAlex
- W2065797209
- Cited by
- 92
- References
- 37
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 1 · 2023: 5 · 2022: 5 · 2021: 9 · 2020: 5 · 2019: 6 · 2018: 9 · 2017: 5 · 2016: 7 · 2015: 10 · 2014: 7 · 2013: 11 · 2012: 5
- FWCI
- 6.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (22791256)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Gastric Cancer Management and Outcomes
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Keywords
- B7-H3, gastric cancer, circulating tumor cells, blood biomarkers, prognostic factors, tumor progression, T cell immunity, overall survival, tumor stage
- MeSH terms
- Adult, Aged, Aged, 80 and over, Female, Humans, Immunohistochemistry, Male, Middle Aged, Neoplastic Cells, Circulating, Neoplasm Staging, Prognosis, Receptors, Immunologic, Stomach Neoplasms, Biomarkers, Tumor, Antigens, CD, Reverse Transcriptase Polymerase Chain Reaction, Kaplan-Meier Estimate, B7 Antigens
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
